← Back to Dashboard

Glycyrrhizin

0

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)…
LPLVUJXQOOQHMX-QWBHMCJMSA-N

Clinical Development by Virus22

Human gammaherpesvirus 4
EBV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Influenza A virus
FLUAV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Hepacivirus C
HCV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus A
EV-A71
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Enterovirus A
CV-A16
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human immunodeficiency virus 1
HIV-1
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human orthorubulavirus 2
HPIV-2
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human alphaherpesvirus 1
HSV-1
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Human gammaherpesvirus 8
KSHV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Rubivirus rubellae
RuV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Dengue virus
DENV-1
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Dengue virus
DENV-2
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Dengue virus
DENV-4
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Japanese encephalitis virus
JEV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
West Nile virus
WNV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Yellow fever virus
YFV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Zika virus
ZIKV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Usutu virus
USUV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Langat virus
LGTV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved
Wesselsbron virus
WESSV
Target: Human TNF
Preclinical
Preclinical
Phase 2
Phase 3
Approved